Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)
. 1975;6:102–112. doi: 10.1136/jcp.s1-6.1.102

Human tumour-associated and tumour-specific antigens: some concepts in relation to clinical oncology.

A M Neville, A M Mackay, J Westwood, C Turberville, D J Laurence
PMCID: PMC1436076  PMID: 95631

Abstract

The concept of tumour-specific antigens is constantly undergoing reappraisal with the development of more sensitive methods for their detection. This has resulted in the finding that the many 'new' antigens produced by human tumours or materials immunologically closely related to them are also present in non-neoplastic tissues, albeit in small amounts. However, other antigens still appear to exist almost entirely in or on tumour cells so that the antigens of human tumours may be subdivided into either tumour-associated macromolecules or tumour-specific antigens. The elucidation of the chemical nature of the tumour-specific antigens may result in important advances in cancer diagnosis and therapy. As many are organ specific, it should be possible to evolve test systems which will enable tumours to be diagnosed and located before they become apparent clinically. On the other hand the tumour-associated macromolecules, of which the oncofetal antigens are the principal examples, are found in elevated amounts in some non-neoplastic disorders. It is now clear that serial estimation of the levels of these macromolecules is of considerably more diagnostic value than single random measurements. Current work is establishing their value in the detection of recurrent and metastatic tumours before they become apparent by other methods, which is probably their most important role, and also their value as aids to monitor therapeutic efficacy. The future use of both types of antigen may unfold a new era in cancer detection and therapy but many basic chemical and immunological studies are needed before their clinical use can be fully defined.

Full text

PDF
102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABELEV G. I., PEROVA S. D., KHRAMKOVA N. I., POSTNIKOVA Z. A., IRLIN I. S. Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation. 1963 Apr;1:174–180. doi: 10.1097/00007890-196301020-00004. [DOI] [PubMed] [Google Scholar]
  2. Allan L. D., Ferguson-Smith M. A., Donald I., Sweet E. M., Gibson A. A. Amniotic-fluid alpha-fetoprotein in the antenatal diagnosis of spina bifida. Lancet. 1973 Sep 8;2(7828):522–525. doi: 10.1016/s0140-6736(73)92347-7. [DOI] [PubMed] [Google Scholar]
  3. Bagshawe K. D., Rogers G. T., Searle F., Wilson H. Blood carcinoembryonic antigen, Regan isoenzyme, and human chorionic gonadotrophin in primary mediastinal carcinoma. Lancet. 1973 Jan 27;1(7796):210–211. doi: 10.1016/s0140-6736(73)90052-4. [DOI] [PubMed] [Google Scholar]
  4. Baldwin R. W., Embleton M. J., Price M. R., Vose B. M. Embryonic antigen expression on experimental rat tumours. Transplant Rev. 1974;20(0):77–99. doi: 10.1111/j.1600-065x.1974.tb00142.x. [DOI] [PubMed] [Google Scholar]
  5. Ballas M. Yolk sac carcinoma of the ovary with alpha fetoprotein in serum and ascitic fluid demonstrated by immunoosmophoresis. Am J Clin Pathol. 1972 Apr;57(4):511–516. doi: 10.1093/ajcp/57.4.511. [DOI] [PubMed] [Google Scholar]
  6. Banjo C., Shuster J., Gold P. Proceedings: Intermolecular heterogeneity of the carcinoembryonic antigen. Cancer Res. 1974 Aug;34(8):2114–2121. [PubMed] [Google Scholar]
  7. Banwo O., Versey J., Hobbs J. R. New oncofetal antigen for human pancreas. Lancet. 1974 Apr;1(7859):643–645. doi: 10.1016/s0140-6736(74)93197-3. [DOI] [PubMed] [Google Scholar]
  8. Braunstein G. D., McIntire K. R., Waldmann T. A. Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas. Cancer. 1973 May;31(5):1065–1068. doi: 10.1002/1097-0142(197305)31:5<1065::aid-cncr2820310505>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  9. Brock D. J., Bolton A. E., Monaghan J. M. Prenatal diagnosis of anencephaly through maternal serum-alphafetoprotein measurement. Lancet. 1973 Oct 27;2(7835):923–924. doi: 10.1016/s0140-6736(73)92592-0. [DOI] [PubMed] [Google Scholar]
  10. Carnegie P. R., Caspary E. A., Field E. J. Isolation of an "antigen" from malignant tumours. Br J Cancer Suppl. 1973 Aug;1:219–223. [PMC free article] [PubMed] [Google Scholar]
  11. Cercek L., Cercek B., Franklin C. I. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders. Br J Cancer. 1974 May;29(5):345–352. doi: 10.1038/bjc.1974.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chu T. M., Nemoto T. Evaluation of carcinoembryonic antigen in human mammary carcinoma. J Natl Cancer Inst. 1973 Oct;51(4):1119–1122. doi: 10.1093/jnci/51.4.1119. [DOI] [PubMed] [Google Scholar]
  13. Coligan J. E., Henkart P. A., Todd C. W., Terry W. D. Heterogeneity of the carcinoembryonic antigen. Immunochemistry. 1973 Sep;10(9):591–599. doi: 10.1016/0019-2791(73)90160-2. [DOI] [PubMed] [Google Scholar]
  14. Coombers G. B., Hall R. R., Laurence J. R., Neville A. M. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal. Br J Cancer. 1975 Feb;31(2):135–142. doi: 10.1038/bjc.1975.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Currie G. The role of circulating antigen as an inhibitor of tumour immunity in man. Br J Cancer Suppl. 1973 Aug;1:153–161. [PMC free article] [PubMed] [Google Scholar]
  16. Denk H., Tappeiner G., Eckerstorfer R., Holzner J. H. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation. Int J Cancer. 1972 Sep 15;10(2):262–272. doi: 10.1002/ijc.2910100206. [DOI] [PubMed] [Google Scholar]
  17. Dickinson J. P., Caspary E. A., Field E. J. A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br J Cancer. 1973 Feb;27(2):99–105. doi: 10.1038/bjc.1973.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dickinson J. P., Caspary E. A. The chemical nature of cancer basic protein. Br J Cancer Suppl. 1973 Aug;1:224–228. [PMC free article] [PubMed] [Google Scholar]
  19. Dickinson J. P., McDermott J. R., Smith J. K., Caspary E. A. A common tumour specific antigen. II. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues. Br J Cancer. 1974 Jun;29(6):425–432. doi: 10.1038/bjc.1974.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Embleton M. J. Significance of tumour associated antigens on human colonic carcinomata. Br J Cancer Suppl. 1973 Aug;1:142–152. [PMC free article] [PubMed] [Google Scholar]
  21. Esterhay R. J., Jr, Shapiro H. M., Sutherland J. C., McIntire K. R., Wiernik P. H. Serum alpha fetoprotein concentration and tumor growth dissociation in a patient with ovarian teratocarcinoma. Cancer. 1973 Apr;31(4):835–839. doi: 10.1002/1097-0142(197304)31:4<835::aid-cncr2820310411>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  22. Field E. J., Caspary E. A. Lymphocyte sensitisation: an in-vitro test for cancer? Lancet. 1970 Dec 26;2(7687):1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
  23. Field E. J., Caspary E. A., Smith K. S. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation. Br J Cancer Suppl. 1973 Aug;1:208–214. [PMC free article] [PubMed] [Google Scholar]
  24. Field E. J., Hughes D., Caspary E. A. Rapid development of a cancer-like antigen in normal tissue in vitro. Br J Cancer. 1973 Jun;27(6):427–433. doi: 10.1038/bjc.1973.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fleisher M., Oettgen H. F., Breed C. N., Robbins G. F., Pinsky C. M., Schwartz M. K. CEA-like material in fluid from benign cysts of the breast. Clin Chem. 1974;20(1):41–42. [PubMed] [Google Scholar]
  26. Gitlin D. Sites of alpha-fetoprotein synthesis. N Engl J Med. 1971 Dec 16;285(25):1436–1437. doi: 10.1056/NEJM197112162852517. [DOI] [PubMed] [Google Scholar]
  27. Gold P., Freedman S. O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481. doi: 10.1084/jem.122.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gold P., Krupey J., Ansari H. Position of the carcinoembryonic antigen of the human digestive system in ultrastructure of tumor cell surface. J Natl Cancer Inst. 1970 Aug;45(2):219–225. [PubMed] [Google Scholar]
  29. Goldstone A. H., Kerr L., Irvine W. J. The macrophage electrophoretic migration test in cancer. Clin Exp Immunol. 1973 Jul;14(3):469–472. [PMC free article] [PubMed] [Google Scholar]
  30. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  31. Häkkinen I. P. FSA-foetal sulphoglycoprotein antigen associated with gastric cancer. Transplant Rev. 1974;20(0):61–76. [PubMed] [Google Scholar]
  32. Khoo S. K., Mackay E. V. Carcinoembryonic antigen in cancer of the female reproductive system: sequential levels and effects of treatment. Aust N Z J Obstet Gynaecol. 1973 Feb;13(1):1–17. doi: 10.1111/j.1479-828x.1973.tb02270.x. [DOI] [PubMed] [Google Scholar]
  33. Khoo S. K., Warner N. L., Lie J. T., Mackay I. R. Carcinoembryonic antigenic activity of tissue extracts: a quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs. Int J Cancer. 1973 May;11(3):681–687. doi: 10.1002/ijc.2910110319. [DOI] [PubMed] [Google Scholar]
  34. Krupey J., Gold P., Freedman S. O. Physicochemical studies of the carcinoembryonic antigens of the human digestive system. J Exp Med. 1968 Sep 1;128(3):387–398. doi: 10.1084/jem.128.3.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Krupey J., Wilson T., Freedman S. O., Gold P. The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue. Immunochemistry. 1972 Jun;9(6):617–622. doi: 10.1016/0019-2791(72)90247-9. [DOI] [PubMed] [Google Scholar]
  36. Laurence D. J., Neville A. M. Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer. 1972 Oct;26(5):335–355. doi: 10.1038/bjc.1972.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Laurence D. J., Stevens U., Bettelheim R., Darcy D., Leese C., Turberville C., Alexander P., Johns E. W., Neville A. M. Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J. 1972 Sep 9;3(5827):605–609. doi: 10.1136/bmj.3.5827.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Leek A. E., Ruoss C. F., Kitau M. J., Chard T. Raised alpha-fetoprotein in maternal serum with anencephalic pregnancy. Lancet. 1973 Aug 18;2(7825):385–385. doi: 10.1016/s0140-6736(73)93236-4. [DOI] [PubMed] [Google Scholar]
  39. Mackay A. M., Patel S., Carter S., Stevens U., Laurence D. J., Cooper E. H., Neville A. M. Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J. 1974 Nov 16;4(5941):382–385. doi: 10.1136/bmj.4.5941.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. McIntire K. R., Vogel C. L., Princler G. L., Patel I. R. Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma. Cancer Res. 1972 Sep;32(9):1941–1946. [PubMed] [Google Scholar]
  41. Nery R., Barsoum A. L., Bullman H., Neville A. M. Carcinoembryonic antigen-like substances of human urothelial carcinomas. Isolation of components from pathological urine and comparison with colorectal carcinoma antigens. Biochem J. 1974 May;139(2):431–440. doi: 10.1042/bj1390431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Nery R., James R., Barsoum A. L., Bullman H. Isolation and partial characterization of macromolecular urinary aggregates containing carcinoembryonic antigen-like activity. Br J Cancer. 1974 Jun;29(6):413–424. doi: 10.1038/bjc.1974.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Neville A. M., Laurence D. J. Report of the workshop on the carcinoembryonic antigen (cea): the present position and proposals for future investigation. Int J Cancer. 1974 Jul 15;14(1):1–1. doi: 10.1002/ijc.2910140102. [DOI] [PubMed] [Google Scholar]
  44. Neville A. M., Nery R., Hall R. R., Turberville C., Laurence D. J. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma. Br J Cancer Suppl. 1973 Aug;1:198–207. [PMC free article] [PubMed] [Google Scholar]
  45. Nishi S. Isolation and characterization of a human fetal-alpha-globulin from the sera of fetuses and a hepatoma patient. Cancer Res. 1970 Oct;30(10):2507–2513. [PubMed] [Google Scholar]
  46. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer. 1973 Jan;27(1):1–9. doi: 10.1038/bjc.1973.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer Suppl. 1973 Aug;1:229–236. [PMC free article] [PubMed] [Google Scholar]
  48. Ravry M., McIntire K. R., Moertel C. G., Waldmann T. A., Schutt A. J., Go V. L. Carcinoembryonic antigen and alpha-fetoprotein in the diagnosis of gastric and colonic cancer: a comparative clinical evaluation. J Natl Cancer Inst. 1974 Mar;52(3):1019–1024. doi: 10.1093/jnci/52.3.1019. [DOI] [PubMed] [Google Scholar]
  49. Ruoslahti E., Pihko H., Seppälä M. Alpha-fetoprotein: immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease. Transplant Rev. 1974;20(0):38–60. doi: 10.1111/j.1600-065x.1974.tb00140.x. [DOI] [PubMed] [Google Scholar]
  50. Ruoslahti E., Seppälä M., Pihko H., Vuopio P. Studies of carcino-fetal proteins. II. Biochemical comparison of -fetoprotein from human fetuses and patients with hepatocellular cancer. Int J Cancer. 1971 Sep 15;8(2):283–288. doi: 10.1002/ijc.2910080213. [DOI] [PubMed] [Google Scholar]
  51. Ruoslahti E., Seppälä M., Vuopio P., Saksela E., Peltokallio P. [Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver]. J Natl Cancer Inst. 1972 Sep;49(3):623–630. [PubMed] [Google Scholar]
  52. Sell S., Nichols M., Becker F. F., Leffert H. L. Hepatocyte proliferation and alpha 1-fetoprotein in pregnant, neonatal, and partially hepatectomized rats. Cancer Res. 1974 Apr;34(4):865–871. [PubMed] [Google Scholar]
  53. Seller M. J., Campbell S., Coltart T. M., Singer J. D. Early termination of anencephalic pregnancy after detection by raised alpha-fetoprotein levels. Lancet. 1973 Jul 14;2(7820):73–73. doi: 10.1016/s0140-6736(73)93264-9. [DOI] [PubMed] [Google Scholar]
  54. Seppälä M., Ruoslahti E. Alpha fetoprotein in maternal serum: a new marker for detection of fetal distress and intrauterine death. Am J Obstet Gynecol. 1973 Jan 1;115(1):48–52. doi: 10.1016/0002-9378(73)90087-2. [DOI] [PubMed] [Google Scholar]
  55. Silver H. K., Deneault J., Gold P., Thompson W. G., Shuster J., Freedman S. O. The detection of alpha 1-fetoprotein in patients with viral hepatitis. Cancer Res. 1974 Jan;34(1):244–247. [PubMed] [Google Scholar]
  56. Silver H. K., Gold P., Shuster J., Javitt N. B., Freedman S. O., Finlayson N. D. Alpha(1)-fetoprotein in chronic liver disease. N Engl J Med. 1974 Sep 5;291(10):506–508. doi: 10.1056/NEJM197409052911006. [DOI] [PubMed] [Google Scholar]
  57. Skarin A. T., Delwiche R., Zamcheck N., Lokich J. J., Frei E., 3rd Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer. 1974 May;33(5):1239–1245. doi: 10.1002/1097-0142(197405)33:5<1239::aid-cncr2820330508>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  58. Steward A. M., Nixon D., Zamcheck N., Aisenberg A. Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer. 1974 May;33(5):1246–1252. doi: 10.1002/1097-0142(197405)33:5<1246::aid-cncr2820330509>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  59. Stonehill E. H., Bendich A. Retrogenetic expression: the reappearance of embryonal antigens in cancer cells. Nature. 1970 Oct 24;228(5269):370–372. doi: 10.1038/228370a0. [DOI] [PubMed] [Google Scholar]
  60. Terry W. D., Henkart P. A., Coligan J. E., Todd C. W. Carcinoembryonic antigen: characterization and clinical applications. Transplant Rev. 1974;20(0):100–129. doi: 10.1111/j.1600-065x.1974.tb00143.x. [DOI] [PubMed] [Google Scholar]
  61. Terry W. D., Henkart P. A., Coligan J. E., Todd C. W. Structural studies of the major glycoprotein in preparations with carcinoembryonic antigen activity. J Exp Med. 1972 Jul 1;136(1):200–204. doi: 10.1084/jem.136.1.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Thomson D. M., Krupey J., Freedman S. O., Gold P. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci U S A. 1969 Sep;64(1):161–167. doi: 10.1073/pnas.64.1.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Turberville C., Darcy D. A., Laurence D. J., Johns E. W., Neville A. M. Studies on carcinoembryonic antigen (CEA) and a related glycoprotein, CCEA-2. Preparation and chemical characterisation. Immunochemistry. 1973 Dec;10(12):841–843. doi: 10.1016/0019-2791(73)90189-4. [DOI] [PubMed] [Google Scholar]
  64. Vincent R. G., Chu T. M. Carcinoembryonic antigen in patients with carcinoma of the lung. J Thorac Cardiovasc Surg. 1973 Aug;66(2):320–328. [PubMed] [Google Scholar]
  65. Westwood J. H., Bessell E. M., Bukhari M. A., Thomas P., Walker J. M. Studies on the structure of the carcinoembryonic antigen. I. some deductions on the basis of chemical degradations. Immunochemistry. 1974 Dec;11(12):811–818. doi: 10.1016/0019-2791(74)90302-4. [DOI] [PubMed] [Google Scholar]
  66. Zimmerman E. F., Madappally M. M. Sialyltransferase: regulation of alpha-foetoprotein microheterogeneity during development. Biochem J. 1973 Jul;134(3):807–810. doi: 10.1042/bj1340807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. von Kleist S., Burtin P. Localisation cellulaire d'un antigène embryonnaire de tumeurs coliques humaines. Int J Cancer. 1969 Nov 15;4(6):874–879. doi: 10.1002/ijc.2910040616. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Ass. Clin. Path.) are provided here courtesy of BMJ Publishing Group

RESOURCES